Exhibit 8.1
October 13, 2020
Royalty Pharma plc
Suite 1
3rd Floor
11 - 12 St. James’s Square
London
United Kingdom
SW1Y 4LB
| Re: | Registration Statement on Form S-1 |
Ladies and Gentlemen:
We have acted as counsel to Royalty Pharma plc (the “Company”), in connection with the preparation and filing of the registration statement on Form S-1 (the “Registration Statement”) filed with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Act of 1933, as amended (the “Securities Act”). The Registration Statement has been filed in connection with the offering for sale by selling shareholders identified therein (the “Offering”) of certain of the Company’s Class A ordinary shares.
For purposes of this opinion, we have reviewed originals, or copies certified or otherwise identified to our satisfaction, of the Registration Statement and the exhibits thereto, and such other documents and matters of law and fact as we have considered necessary or appropriate. In addition, we have not made an independent investigation or audit of the facts set forth in the above referenced documents or otherwise provided to us. We have assumed (i) the authenticity of all documents submitted to us as originals and the conformity to original documents of all documents submitted to us as copies, (ii) that the Offering will be consummated as described in the Registration Statement; (iii) that the statements concerning the terms of the Offering set forth in the Registration Statement are true, complete and correct and will remain true, complete and correct at all relevant times; and (iv) that any such statements made in the Registration Statement qualified by knowledge, intention, belief or any other similar qualification are true, complete and correct, and will remain true, complete and correct at all relevant times, in each case as if made without such qualification. If any of the above described assumptions are untrue for any reason or if the Offering is consummated in a manner that is different from the manner described in the Registration Statement, our opinion as expressed below may be adversely affected.
Based upon and subject to the foregoing, and our consideration of such other matters of fact and law as we have considered necessary or appropriate, the statements set forth under the captions “Material Tax Considerations-Material U.K. Tax Considerations” and “Material Tax Considerations—Material U.S. Federal Income Tax Considerations” in the Registration Statement, to the extent such statements summarize U.K. tax law and U.S. federal income tax law, and subject to the limitations, qualifications, exceptions, and assumptions set forth herein and therein, set forth the material U.K. tax considerations and the material U.S. federal income tax considerations related to the purchase, ownership and disposition of the Company’s Class A ordinary shares as of the date hereof in our opinion.